Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Haggenburg, SabineLissenberg-Witte, Birgit I
Van BInnendijk, Rob S
den Hartog, Gerco
Bhoekhan, Michel S
Haverkate, Nienke J E
De Rooij, Dennis Michel
van Meerloo, Johan
Cloos, Jacqueline
Kootstra, Neeltje A
Wouters, Dorine
Weijers, Suzanne S
van Leeuwen, Ester M M
Bontkes, Hetty J
Tonouh-Aajoud, Saida
Heemskerk, Mirjam H M
Sanders, Rogier
Roelandse-Koop, Elianne
Hofsink, Quincy
Groen, Kazimierz
Çetinel, Lusia A
Schellekens, Louis
den Hartog, Yvonne M
Toussaint, Belle
Kant, Iris M J
Graas/Bouman, Thecla Margaretha
de Pater, Emma
Dik, Willem Arnout
Engel, Marije D
Pierie, Cheyenne R N
Janssen, Susanne R
van Dijkman, Edith
Poniman, Meliawati
Burger, Judith A
Bouhuijs, Joey H
Smits, Gaby
Rots, Nynke Y
Zweegman, Sonja
Kater, A P
van Meerten, Tom
Mutsaers, Pim G N J
van Doesum, Jaap
Broers, Annoek E C
van Gils, Marit
Goorhuis, Abraham
Rutten, Caroline
Hazenberg, Mette D
Nijhof, Inger S
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.Published in
Blood advances 2022; 6(5):1536-46PMID
35114690ae974a485f413a2113503eed53cd6c53
10.1182/bloodadvances.2021006917
Scopus Count
Collections
Related articles
- Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
- Authors: Haggenburg S, Hofsink Q, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS, COBRA KAI Study Team
- Issue date: 2022 Oct 1
- Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
- Authors: Scaggs Huang F
- Issue date: 2022 Apr 30
- Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
- Authors: Huang A, Cicin-Sain C, Pasin C, Epp S, Audigé A, Müller NJ, Nilsson J, Bankova A, Wolfensberger N, Vilinovszki O, Nair G, Hockl P, Schanz U, Kouyos RD, Hasse B, Zinkernagel AS, Trkola A, Manz MG, Abela IA, Müller AMS
- Issue date: 2022 Apr
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
- Authors: Maneikis K, Šablauskas K, Ringelevičiūtė U, Vaitekėnaitė V, Čekauskienė R, Kryžauskaitė L, Naumovas D, Banys V, Pečeliūnas V, Beinortas T, Griškevičius L
- Issue date: 2021 Aug
- Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.
- Authors: Pascale SP, Nuccorini R, Pierri T, Di Mare R, Fabio L, Lerose E, Merlino MA, Schiavo P, Amendola A, Brucoli G, Caputo MD, Chitarrelli I, Cimminiello M, Coluzzi S, Filardi NB, Matturro A, Vertone D, Poggiaspalla M, Malaspina F, Musuraca G, Coralluzzo G, Mannarella C, Musto C, Bellettieri AP, Martinelli G, Cerchione C, Pizzuti M
- Issue date: 2022